Inhaled <i>DNAI1</i> mRNA therapy for treatment of primary ciliary dyskinesia
M. Hennig(Io Therapeutics (United States)), Brandon A. Wustman(Rapt Therapeutics (United States))
Cited by 10
Related Papers
Structure of acid β-glucosidase with pharmacological chaperone provides insight into Gaucher disease
|Nature Chemical Biology|2006|242